Parkinson s Research and the New Centre for Brain Health at UBC. Case for Support The University of British Columbia Faculty of Medicine

Similar documents
AUSTRALIA'S ONLY DEDICATED ACADEMIC DEPARTMENT OF NEUROSCIENCE.

UC HEALTH RESEARCH INSTITUTE STRATEGIC PLAN

THE CANADA-ISRAEL TRANS-ATLANTIC COLLABORATION FOR BRAIN STUDIES

ADOLESCENT MEDICINE SUBSPECIALTY RESIDENCY/FELLOWSHIP PROGRAM DESCRIPTION

Strategic Plan

Summary Transforming healthcare for women and newborns

BACK TO SPINAL RESEARCH

Neurofibromatosis (NF) Center

UC San Diego HIV Institute Creating a Future Without HIV/AIDS

Glen Sather Sports Medicine Clinic Research Strategy

World Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee

annual report

The summit and its purpose

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

OUR STRATEGIC PLAN

VISION» FOCUS DISCOVERY» CREATION

Consultation on Australian Medical Research and Innovation Priorities for

AUSTRALIA S FIRST DEDICATED DEPARTMENT OF DIABETES. med.monash.edu/cecs/diabetes

Type 1 Diabetes Australian Research Impact Analysis

Canadian Mental Health Association

Prof. Anne McKinney D.Phil Associate Vice-Principal, Research & Innovation (Health Affairs) McGill University.

Joint Programming in Neurodegenerative Disease Research (JPND)

With your help, our goal is to protect millions more against serious illness through the development of new vaccines and other preventions.

PEDIATRIC OTOLARYNGOLOGY FELLOWSHIP. B.C. Children s Hospital University of British Columbia Vancouver, B.C.

Australasian Sleep Association

Health Equity at The Hospital for Sick Children Meeting of The Task Force for Migrant Friendly and Culturally Competent HealthCare

First US Plan to Address Alzheimer s Disease

Memory Research Suite

Achievements

Legend. Innovations in Treatment and Recovery. Industry Symposia Oral Communications E Short Communications SUNDAY FEBRUARY 25, 2018

Translating Duke Health. Accelerating discovery and its translation

Treatments of tomorrow: dementia research and drug discovery. Dr Matthew Norton Director of Policy and Strategy, Alzheimer s Research UK

CANADIAN DIABETES ASSOCIATION

A Four Point Plan for Enhanced Support for Parkinson s Disease In B.C.

PSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development

BRAIN MISSION Understand - fix - enhance

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Defeat Dementia. Five years and 100m of investment to power transformational patient benefit

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

BioArctic announces positive topline results of BAN2401 Phase 2b at 18 months in early Alzheimer s Disease

University of Cincinnati Heart, Lung & Vascular Institute

The Ayrshire Hospice

Innovative Canadian PSR Education and Practice. PSR/RPS Canada, 2014! John Higenbottam,! Regina Casey and Matthew Laing

Children s Research Institute

Research Strategic Plan

PEDIATRIC OTOLARYNGOLOGY-HEAD AND NECK SURGERY CLINICAL FELLOWSHIP. B.C. Children s Hospital University of British Columbia Vancouver, B.C.

RESEARCH EDUCATION COMMUNITY STRATEGIC PLAN

BUILDING COLLABORATIONS WITH OUR CLINICAL COLLEAGUES TO DO RESEARCH:

Adverse Childhood Experiences Summit: BC & Beyond

A World Free From Cancer. BC Cancer Foundation 2011 Report to Donors

The G8 Dementia Summit: A Giant Step Forward for Dementia

ALBERTA PRINCIPAL INVESTIGATORS

ONLY AT NYSCF Stem Cells in the City Sponsorship Offering

2 nd International Conference On DEMENTIA AND DEMENTIA CARE. Dementia April 15-16, 2019 Toronto, Canada

Welcome Note by Dr. Helge Braun, Parliamentary State Secretary

Manitoba Action Plan for Sport (MAPS)

HTH Page 1

Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse

STRATEGIC DIRECTIONS AND FUTURE ACTIONS: Healthy Aging and Continuing Care in Alberta

DEPARTMENT OF Pathology

Role Description: Regional Colon Cancer Screening/GI Endoscopy Clinical Lead

PROJECT TRICALS AN INTERNATIONAL COLLABORATION TO FIND EFFECTIVE TREATMENTS FOR AMYOTROPHIC LATERAL SCLEROSIS

The Lung Cancer Network: Collaborate to Cure

FY12 FY14 Strategic Plan

Counting down to zero

CHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE

Council of the European Union Brussels, 28 October 2015 (OR. en)

Brain research supported by the European Union

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

Strategic Directions

Association of American Cancer Institutes

Merkin Brain and Health Policy Innovation Program 2013

Strategic Vision. Transforming Health Care

Finding Adequate Reward in Life: Dopamine and the Brain

I. Introduction. II. Program Description

alzheimer S and ParkiNSoN S integrated HealtH SerViceS Better BaNDaGeS

UCSF Osher Center for Integrative Medicine. Your life, your health, your choice.

OUTLINE AAHPM & HPNA Annual Assembly DISCLOSURE. Dr. Hagen has no conflict of interest to report. Shaping public policy and enhancing care

International collaboration to develop inhaled form of oxytocin to manage bleeding after childbirth in developing countries

Strategic Plan Executive Summary Society for Research on Nicotine and Tobacco

INSERT COMPANY LOGO HERE

UICC Members Regional Meeting. North America & Global Collaborations

SALTY Improving End of Life Care in Long Term Care Janice Keefe Scientific Lead and Co Lead Stream 4

Presentation to the Standing Committee on Health Chronic Diseases Related to Aging. October 17, 2011

PUBLIC POLICIES AND ALZHEIMER RESEARCH

2016 ADHD Conference Speaker Biographies

The 16th Annual Geriatric Services Conference PROGRAM

MSc In Translational Neuroscience.

Canadian Mental Health Association

An Extraordinary Resource for Cancer Care

Health for Humanity 2020 Goals 2

IMAGING MEDICAL PHYSICS IN CANADA

Yukon Palliative Care Framework

ASBMR. Institute of Musculoskeletal Health and Arthritis (IMHA) Dr. Hani El-Gabalawy Scientific Director Canadian Institutes of Health Research

SUBSTANCE USE DISORDERS

ESRC-NIHR dementia research initiative 2018 outline call Call specification

CDNF: Finnish academia-industry collaboration for unique clinical study in Parkinson s disease

Parkinson s Foundation Nurse Course Faculty

DEPARTMENT OF ONCOLOGY STRATEGIC PLANNING SURVEY THEMES

Center for Cell Therapy and Regenerative Medicine (CCRG)

Transcription:

Parkinson s Research and the New Centre for Brain Health at UBC Case for Support The University of British Columbia Faculty of Medicine

THE VALUE OF A HEALTHY BRAIN By 2020, brain disease will overtake heart disease and cancer as the leading cause of death and disability in Canada. Affecting 1 in 7 Canadians, from early childhood to old age, brain dysfunction costs over $30 billion annually, and places enormous strain on affected individuals, their families, health care systems, and the economy. Understanding how a healthy brain works is essential to preventing and treating brain disease, and both are essential to an individual s health and wellbeing. GLOBAL IMPACTS OF NEUROLOGICAL DISORDERS The approaching silver tsunami of retirees in Western nations will radically increase the number of people at risk for brain dysfunction, which can manifest as Parkinson s or Alzheimer s disease, other dementias, or depression. According to the World Health Organization, it is projected that, worldwide, the number of people affected by dementia will double every 20 years. Neurological disorders, and some of the other conditions with neurological impairments and their aftereffects, constitute over 6 percent of the global burden of disease. This burden is especially high in many low and middle income countries. Responding to community needs requires an improved understanding of the brain and improvements to brain healthcare delivery. At stake is not only the mental health of many individuals, but on a larger scale, the social and economic welfare of nations. AN INTEGRATED VISION AND APPROACH TO BRAIN HEALTH Around the mid-20th century, western healthcare reached a critical turning point when the discipline of neurology diverged from psychiatry. This division generated specialized departments and clinical training programs, which to this day remain separate. This fundamental separation is compounded by institutional divisions between basic research and clinical care. In the 21st century, it is clear that a healthy society demands an integration of neurology and psychiatry with basic brain research, and the connection of discoveryfocused research with the delivery of clinical treatment. The new Centre for Brain Health at UBC provides a unique, home-grown answer to this world-wide problem. The first of its kind in the world, the Centre for Brain Health will enable a new model of neurological and psychiatric healthcare delivery that integrates with discovery brain research. The goal is to understand how the healthy brain changes in form and function, resulting in brain dysfunction, and how to treat and prevent these changes. The work at this patient-focused, truly interdisciplinary Centre will impact advancements in brain health on a global scale.

The Centre will integrate basic neurosciences, psychiatry, neurology, and clinical care. In the first phase, a new hub for training, care delivery, and research crossing all facets of brain health will be created on the UBC Point Grey campus. This hub will incorporate the Brain Research Centre which includes the Pacific Parkinson's Research Centre the Division of Neurology, the Department of Psychiatry, the Institute of Mental Health, and the BC Centre for Excellence in Addiction and Concurrent Disorders. The Centre for Brain Health is a joint initiative of the UBC Faculty of Medicine and UBC & VGH Hospital Foundation. Healthcare partners include the Brain Research Centre, Vancouver Coastal Health, the Provincial Health Services Authority, and the UBC Faculty of Medicine s Department of Psychiatry and Division of Neurology. The Centre will encourage and facilitate patients and their families participation as active partners in the research and care delivery processes. This new initiative will create an innovative opportunity to deliver translational, bench-to-bedside research to the population at large, and to accelerate the fight against brain disease. THE CENTRE FOR BRAIN HEALTH: PATIENT-CENTRED RESEARCH AND CARE The Centre will significantly benefit Parkinson s patients health and wellbeing. The UBC Faculty of Medicine, Provincial Health Services, and Vancouver Coastal Health Authorities each devote impressive resources and expertise to the study and treatment of brain disease. The various clinics and research centres are currently separate units, however, which limits opportunities for collaboration and integration between research and treatment. Parkinson s patients must make multiple visits to multiple locations a major disincentive to participation. With neurologic and psychiatric clinics and scientists in the same facility, Parkinson s patients and their families will not only be able to participate in research but will also have better access to interdisciplinary care and to faster delivery of outcomes. This will dramatically increase the ability of researchers to complete research and clinical trials of promising therapeutics in the age of genomic health care. SHARING DISCOVERIES WITH THE INTERNATIONAL COMMUNITY The Centre s translational research will have international impact, as our researchers are affiliated with institutes and research centres around the world, in countries such as the United States, Australia, the United Kingdom, France, Germany, Spain, Italy, Hungary, Venezuela, China, and Japan. Central to the vision of the Centre for Brain Health is the creation of opportunities for advancing world-class research through integration and collaboration. Within this

model, Parkinson s investigators will position their research programs within both the network and physically, within the Centre, building on the relevant discoveries of each and allowing for an effective transfer of knowledge. THE PACIFIC PARKINSON S RESEARCH CENTRE The Pacific Parkinson's Research Centre (PPRC) acts as a centre of excellence for diagnosis and management of Parkinson's and other related disorders. Headed by Dr. Jon Stoessl, an internationally recognized expert on Parkinson s disease, PPRC conducts a strong research program that spans preclinical, clinical, and population studies. PPRC serves as both a research and clinical unit. It is the major referral base for the diagnosis and assessment of Parkinson's disease and other movement disorders for the province of British Columbia. Approximately 3,500 clinic visits are conducted annually, including approximately 1,500 people with Parkinson's disease. The research and clinical activities of the Centre are closely intertwined and, indeed, many patients choose to attend the Movement Disorders Clinic at the Centre specifically so that they may participate in research studies. PPRC conducts one of the largest peer-reviewed Parkinson's disease research programs in Canada, with a focus on the use of Positron Emission Tomography and, more recently, functional fmri to study the natural history and progression of Parkinson's disease, genetic forms of Parkinson's, the complications of long-term disease, and its therapy and the placebo effect. Dr. Stoessl and his colleagues were the first to demonstrate that the placebo effect in Parkinson s disease is mediated by the release of dopamine in the brain. This work, originally published in Science, has received international attention by the scientific community and the media and was featured on the BBC. The work on genetic causes of Parkinson's has been conducted in collaboration primarily with Dr. Z. Wszolek at the Mayo Clinic in Jacksonville, Florida, and has resulted in publications in Neuron, Neurology and Brain. Work on complications of Parkinson's has resulted in publications in Annals of Neurology and Brain. As a Center of Excellence of the US-based National Parkinson Foundation, PPRC is one of 43 leading medical centres networked worldwide that altogether deliver care to more than 50,000 Parkinson s patients. A MODEL OF INTERDISCIPLINARY RESEARCH AND PATIENT CARE Through its integrated approach to healthcare for Parkinson s patients, the PPRC serves as a model for the vision of the new Centre for Brain Health at UBC. Clinical problems and patient participation drive the research being conducted on clinically important

questions, which then gets translated back to excellence in patient care. To the extent that current facilities permit, an interdisciplinary approach to both clinical care and research is pursued, as PPRC staff members recognize that Parkinson s is much more than a problem of the motor system. Research being undertaken at the PPRC integrates and draws on knowledge derived from neurology, psychiatry, and basic neuroscience, and contributes to research being conducted in other disciplines. This removal of traditional boundaries and one-stop-shop model of patient care will be adopted by all research clinics throughout the new Centre for Brain Health, which will bring together neurological and psychiatric clinical services with interdisciplinary and translational research. This integrated approach represents a major shift in how brain disorders are treated and could lead to significant improvements and efficiencies, as well as breakthrough discoveries and developments. CURRENT PARKINSON S RESEARCH ACTIVITIES AT PPRC PPRC comprises neurologist clinician-scientists whose practice is restricted to movement disorders, preclinical neuroscientists, and imaging scientists, with appointments in Neurology, Physics and Astronomy, Pharmaceutical Sciences, and TRIUMF (where the isotopes for Positron Emission Tomography or PET brain scans are produced), as well as preclinical and clinical investigators in Psychiatry and in Health Care and Epidemiology. Training is an important aspect of PPRC s activities and at any given time, there are usually two to three clinical fellows as well as numerous graduate students and postdoctoral fellows. Clinical fellows may be from Canada, the US, or overseas and are typically expected to establish centres of expertise elsewhere upon completion of their training at UBC. The research program at PPRC is focused on three overarching questions: 1. What causes Parkinson's disease? 2. What causes the complications of Parkinson's and how can we improve existing treatments? 3. What lessons can we learn from Parkinson's about the function of the brain? PPRC investigators are exploring both environmental and genetic causes of Parkinson's. They are studying compensatory changes that occur in the brains of patients with Parkinson's, including people from high-risk families who have not yet developed symptoms, the mechanisms that contribute to complications of Parkinson's, including problems that affect the motor system and psychiatric and cognitive complications. PPCRC investigators in conjunction with other investigators at UBC and those at the Mayo Clinic are also conducting multidisciplinary work on neurodegenerative overlap syndromes resulting in dementia.

These studies offer an outstanding opportunity to better understand the normal role of dopamine in the brain, particularly in signaling reward and motivation. PPRC investigators performed groundbreaking work on the role of dopamine release in the placebo effect in Parkinson's and this forms the basis for ongoing studies being conducted in collaboration with clinical and preclinical neuroscientists in the Department of Psychiatry. SUPPORTING PARKINSON S RESEARCH: OPPORTUNITIES FOR LEADERSHIP Opportunities remain for visionary individuals to take a leadership role in supporting the Pacific Parkinson s Research Centre, pioneering critical advances in health. The PPRC welcomes partnerships to support the operation of its new space in the Centre for Brain Health at UBC, as well as the recruitment and retention of world-class researchers to support current and new research programs. While naming opportunities exist for each of these areas of support, an overarching investment in the PPRC s entire operations and research programming comes with naming opportunities at the $10-million level. The path toward healthier and happier lives is before us. Creating excellence in Parkinson s research, care and facilities is a major step toward a healthier future for all. For additional information on this exciting opportunity, please feel free to contact Fatima Hassam, Associate Director in the UBC Faculty of Medicine s Development Office by phone (604-822-8079) or email (fatima.hassam@ubc.ca).